Sterling Investment Advisors, Ltd. Compugen LTD Transaction History

Sterling Investment Advisors, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$1.57 - $3.33 $4,710 - $9,990	3,000 Added 100.0%	6,000 $11,000
Q3 2021 Nov 09, 2021	BUY	$5.8 - $8.02 $17,400 - $24,060	3,000 New	3,000 $18,000
Q1 2021 May 04, 2021	SELL	$7.67 - $13.77 $8,053 - $14,458	-1,050 Closed	0 $0
Q3 2020 Oct 26, 2020	SELL	$14.16 - $19.45 $14,160 - $19,450	-1,000 Reduced 48.78%	1,050 $17,000
Q2 2020 Jul 24, 2020	BUY	$6.97 - $17.12 $348 - $856	50 Added 2.5%	2,050 $30,000
Q3 2019 Oct 15, 2019	SELL	$3.01 - $4.49 $3,010 - $4,490	-1,000 Reduced 33.33%	2,000 $8,000
Q1 2019 May 01, 2019	BUY	$2.35 - $4.19 $4,700 - $8,380	2,000 Added 200.0%	3,000 $12,000
Q1 2018 Apr 23, 2018	BUY	$2.5 - $4.45 $2,500 - $4,450	1,000 New	1,000 $4,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $129M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.